Compare BLLN & VIRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BLLN | VIRT |
|---|---|---|
| Founded | 2016 | 2008 |
| Country | United States | United States |
| Employees | 713 | N/A |
| Industry | Medical Specialities | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 4.8B |
| IPO Year | N/A | 2014 |
| Metric | BLLN | VIRT |
|---|---|---|
| Price | $128.58 | $56.96 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 5 |
| Target Price | ★ $126.71 | $45.60 |
| AVG Volume (30 Days) | 706.5K | ★ 1.3M |
| Earning Date | 05-06-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 1.89% |
| EPS Growth | N/A | ★ 72.73 |
| EPS | N/A | ★ 1.99 |
| Revenue | N/A | ★ $3,632,118,000.00 |
| Revenue This Year | $46.29 | N/A |
| Revenue Next Year | $30.14 | $1.34 |
| P/E Ratio | ★ N/A | $28.47 |
| Revenue Growth | N/A | ★ 26.25 |
| 52 Week Low | $61.96 | $31.55 |
| 52 Week High | $138.70 | $68.02 |
| Indicator | BLLN | VIRT |
|---|---|---|
| Relative Strength Index (RSI) | 63.97 | 44.91 |
| Support Level | $79.07 | $56.81 |
| Resistance Level | $138.70 | $64.88 |
| Average True Range (ATR) | 6.93 | 2.29 |
| MACD | -0.21 | -1.14 |
| Stochastic Oscillator | 91.96 | 15.26 |
BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.
Virtu Financial Inc is a financial firm that leverages technology to deliver liquidity to the world-wide markets and transparent trading solutions to its clients. The company's operating segment includes Market Making; and Execution Services. The non-operating segment of the company includes the Corporate segment. The company generates maximum revenue from the market-making segment. The Market Making segment principally consists of market-making in the cash, futures, and options markets across equities, options, fixed income, currencies, and commodities. Geographically, it derives a majority of its revenue from the United States and also has a presence in Ireland and Other Countries.